The Claim
Apigenin suppresses adipocyte differentiation in mouse 3T3-L1 preadipocytes by activating AMPK, which reduces the expression of the adipogenic transcription factors PPARγ and C/EBPα and decreases intracellular lipid accumulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin reduces the formation of fat cells in mouse preadipocytes by activating AMPK, which lowers levels of PPARγ and C/EBPα proteins and decreases lipid storage.
See the scientific wording
Apigenin suppresses adipocyte differentiation in mouse 3T3-L1 preadipocytes by activating AMPK, leading to reduced expression of adipogenic transcription factors PPARγ and C/EBPα, and decreased accumulation of intracellular lipids, suggesting a potential molecular mechanism for inhibiting fat cell formation in vitro.
Apigenin turns on a cellular energy sensor called AMPK, which shuts down the master switches that tell cells to become fat cells. This stops the production of proteins that build fat stores, leading to less fat inside the cells.
What the research says
1 studyStudy: Antiadipogenic effect of dietary apigenin through activation of AMPK in 3T3-L1 cells.
Apigenin, a natural compound in plants, was shown to stop fat cells from forming in lab-grown mouse cells by switching on a protein called AMPK, which then turns down the genes that make fat cells grow and store fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.